carnitine has been researched along with Prostatic Hyperplasia in 1 studies
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L | 1 |
Wang, J | 1 |
Mouser, G | 1 |
Li, YC | 1 |
Marcovici, G | 1 |
1 other study available for carnitine and Prostatic Hyperplasia
Article | Year |
---|---|
Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgens; Carnitine; Finasteride; Hair Follicle; Humans; Ma | 2016 |